Atlas Trials

Aqumen Biopharmaceuticals, N.A.

2 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Aqumen Biopharmaceuticals, N.A.

RecordFirmDate
DY002: Safety and Effectiveness of DYME as an Agent for Selective Staining of the Anterior Capsule During Cataract Surgery (NCT00596492)Aqumen Biopharmaceuticals, N.A.2008-05-01
DY001: Safety and Effectiveness of DYME as an Agent for Selective Staining of the Anterior Capsule During Cataract Surgery (NCT00596583)Aqumen Biopharmaceuticals, N.A.2007-04-01

Track Aqumen Biopharmaceuticals, N.A. automatically

Every clearance here is in the API, with alerts when new ones post.